Fulgent Genetics Partners with Parkinson’s Foundation on Launch of Genetic Testing Initiative for People with Parkinson’s Disease
July 16, 2019 09:15 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) and the Parkinson’s Foundation today announced a collaboration on a new genetic testing initiative for...
Fulgent Genetics Reports First Quarter 2019 Financial Results
May 07, 2019 16:05 ET
|
Fulgent Genetics, Inc.
First Quarter 2019 Results: Revenue totals $5.4 million, growing 15% year over yearBillable tests delivered total 7,530, growing 63% year over yearGAAP loss of $1.9 million, or $0.10 per...
Fulgent Genetics to Announce First Quarter 2019 Financial Results on Tuesday May 7, 2019
April 18, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2019...
Fulgent Genetics Reports Fourth Quarter and Full Year 2018 Financial Results
February 28, 2019 16:05 ET
|
Fulgent Genetics, Inc.
Fourth Quarter 2018 Results: Revenue totals $5.7 million, growing 33% year over yearBillable tests delivered total 6,408, growing 52% year over yearGAAP loss of $935,000, or $0.05 per shareNon-GAAP...
Fulgent Genetics to Announce Fourth Quarter and Full Year 2018 Financial Results on Thursday February 28, 2019
February 20, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full...
Fulgent Genetics and Columbia University Irving Medical Center Partner on Expanded Carrier Screening
January 03, 2019 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) and the Precision Genomics Laboratory (PGL), in collaboration with the Department of Obstetrics and Gynecology,...
Representatives of Fulgent Genetics to Participate in the Piper Jaffray 30th Annual Healthcare Conference
November 27, 2018 16:05 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics Reports Third Quarter 2018 Financial Results
November 06, 2018 16:05 ET
|
Fulgent Genetics, Inc.
Third Quarter 2018 Results: Revenue totals $5.6 million, growing 25% year over year and 4% sequentiallyBillable tests delivered total 5,569, growing 37% year over yearGAAP gross margin improves...
Fulgent Genetics to Announce Third Quarter 2018 Financial Results on Tuesday November 6, 2018
October 23, 2018 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2018...
Fulgent Genetics Reports Second Quarter 2018 Financial Results
August 06, 2018 16:05 ET
|
Fulgent Genetics, Inc.
Second Quarter 2018 Results: Revenue totals $5.4 million, growing 16% year over year and 16% sequentiallyBillable tests delivered total 5,700, growing 47% year over year and 23% sequentiallyGAAP and...